共查询到19条相似文献，搜索用时 234 毫秒
1.
替米考星用于鸡毒支原体和大肠杆菌混合感染的临床试验 总被引：2，自引：1，他引：2
试验以人工诱发鸡毒支原体和大肠杆菌混合感染为模型,以酒石酸泰乐菌素为对照药物,评价替米考星溶液的疗效。按每升水加入400m g、200m g、100m g替米考星及500m g酒石酸泰乐菌素的用量给病鸡饮水给药,连用5天。试验表明:替米考星大剂量和中剂量组料肉比与药物对照差异不显著(P>0.05),与其余各组差异极显著(P<0.01)。大剂量组与中剂量组气囊损伤评分与其他各组比较差异极显著(P<0.01),表明大、中剂量均能明显减轻支原体和大肠杆菌混合感染引起的气囊损伤。大剂量和中剂量组的死亡率与药物对照组相比差异均不显著(P>0.05),与其余各组相比差异极显著(P<0.01)。从治愈率来看,大剂量组中剂量组与其他各组相比差异极显著(P<0.01),而小剂量组与药物对照组的治愈率相当(P>0.05)。数据分析表明:替米考星溶液中剂量组能有效地降低气囊损伤度,提高饲料转化率。 相似文献
2.
3.
双原清对猪支原体病的治疗试验 总被引：1，自引：0，他引：1
以人工诱发猪支原体感染为模型,以酒石酸泰乐菌素为对照药物,评价了进口泰妙菌素与双原清（国产泰妙菌素）的疗效。按照每吨饲料中分别添加进口泰妙菌素65ppm和150ppm金霉素,双原清65ppm和150ppm金霉素,酒石酸泰乐菌素150ppm和150ppm金霉素,150ppm金霉素4组进行连续30d添加。试验结果表明双原清可明显控制猪支原体病,提高育成猪的增重,改善料肉比,同时双原清（国产泰妙菌素）与进口泰妙菌素在使用效果中无明显差异。 相似文献
4.
泰乐菌素在肉仔鸡日粮中的应用 总被引：1，自引：0，他引：1
选用ＡＡ公雏４８０只，随机分为５个处理（２０ｍｇ／ｋｇ酒石酸泰乐菌素；１０ｍｇ／ｋｇ酒石酸泰乐菌素；８．５ｍｇ／ｋｇ磷酸泰乐菌素；４０ｍｇ／ｋｇ金霉素；５０ｍｇ／ｋｇ洛克沙生），每个处理８个重复，每个重复１２只鸡，三阶梯笼养。试验表明：在用药期（１～６周）及整个试验期（１～７周）内，三个泰乐菌素处理组的增重高于金霉素和洛克沙生组，料肉比低于金霉素和洛克沙生组，但尚未达到统计学显著水平（Ｐ＞０．０５）；在肉仔鸡日粮中，添加１０ｍｇ／ｋｇ的酒石酸泰乐菌素即可发挥作用，将其添加量提高至２０ｍｇ／ｋｇ水平，并未进一步提高鸡的生产性能。从经济效益及环保和卫生角度考虑，肉仔鸡日粮中酒石酸泰乐菌素的添加水平以１０ｍｇ／ｋｇ为宜。 相似文献
5.
为了研究延胡索酸泰妙菌素对猪支原体肺炎的临床疗效,选用体重90 kg左右的2月龄健康杜洛克长白杂交猪,通过建立疾病模型和疗效评价指标判别延胡索酸泰妙菌素的治疗效果。结果表明,按1000 kg饲料添加100 g或200 g延胡索酸泰妙菌素,可以显著减轻感染猪的临床症状和病理变化,提高猪的增重,其效果优于磷酸泰乐菌素预混剂。 相似文献
6.
利用酒石酸泰乐菌素在试管中对鸡毒支原体进行了抑菌试验和在鸡体内对人工诱发的鸡毒支原体病进行了治疗试验。结果表明 :酒石酸泰乐菌素能有效地抑制试管中鸡毒支原体的生长繁殖。当饮水中药物浓度达到250mg/L以上时 ,能提高感染鸡的成活率 ;当饮水中药物浓度达到500mg/L以上时能降低气囊损伤 ,对提高鸡体增重也有一定的作用 ;当浓度达到1000mg/L时 ,则部分治疗的感染鸡体内检测不到鸡毒支原体抗体。国产酒石酸泰乐菌素作用与进口酒石酸泰乐菌素相接近 相似文献
7.
480只AA公雏随机分为5个处理,分别添加不同水平的酒石酸泰乐菌素、磷酸泰乐菌素、金霉素和洛克沙生。经7周的试验结果表明,3个泰乐菌素处理组的增重高于其他2组,（差异不显著,P＞0．05）和低药残。 相似文献
8.
《中国兽医杂志》2015,(11)
为了评价复方延胡索酸泰妙菌素可溶性粉对猪支原体肺炎的治疗效果,在饮水中添加30、45、60 mg/L复方延胡索酸泰妙菌素可溶性粉,对猪支原体肺炎进行混饮治疗,同时设立支原净对照组。试验结果表明,复方延胡索酸泰妙菌素可溶性粉剂量为45、60mg/L两个试验组中有效率、治愈率、肺损伤改善率、相对日增重率、料重比与支原净基本相同。复方延胡索酸泰妙菌素可溶性粉剂量为60 mg/L试验组中有效率为100%,治愈率为95%;复方延胡索酸泰妙菌素可溶性粉剂量为45 mg/L试验组中有效率为95%,治愈率为90%。南此得知,复方延胡索酸泰妙菌素可溶性粉在饮水中的推荐混合剂量应为45~60 mg/L。 相似文献
9.
贺军 《国外畜牧学(猪与禽)》2016,(11):48-50
本试验表明:日粮粗蛋白水平对6~10周龄白羽肉杂鸡料重比、日增重有极显著影响(P0.01),低蛋白组与中蛋白组间、中蛋白组与高蛋白组间有显著差异(0.01P0.05);随日粮粗蛋白水平升高,平均日采食量下降,较高粗蛋白水平(18%)可以显著降低6~10周龄白羽肉杂鸡(♂)的采食量。以日增重、料重比为衡量指标,日粮代谢能为12.55 MJ/kg,粗蛋白质水平为18%时6~10周龄白羽肉杂鸡日增重最高、料肉比最佳。 相似文献
10.
利用酒石酸泰乐菌素在试管中对鸡毒支原体进行了抑菌试验和在鸡体内对人工诱发的鸡毒支原体病进行了治疗试验。结果表明,酒石酸泰乐菌素能有效地抑制试管中鸡毒支原体的生长繁殖。当饮水中药物浓达到２５０ｍｇ／Ｌ以上时,能提高感染鸡的成活率,当饮水中药物浓度达到５００ｍｇ／Ｌ以上时能降低气囊损伤,对提高鸡体增重也有一定的作用;当浓度达到１０００ｍｇ／Ｌ时,则部分治疗的感染鸡体内检测不到鸡毒支原体抗休画产酒石酸泰 相似文献
11.
《The Journal of Applied Poultry Research》2018,27(1):16-22
Circadian variation of serum concentrations of tylosin in broiler chickens after in-feed medication prompted a comparison study of the serum profiles of this drug after in-feed medication with standard tylosin phosphate (Tprf reference formulation group), and after in-feed medication with a sustained-release pellet formulation (Tpsr group), based on Patent No.MX/a/2012/013222 and PCT/MX2013/000137, in broiler chickens. Six hundred 4-week-old Ross broiler chickens were in-feed medicated with tylosin phosphate at an approximate dose of 25.2 mg/kg/d, based on daily feed consumption values and a final concentration of tylosin in feed of 200 mg/kg of feed. Approximately 2 to 3 mL of blood were obtained per 5 chickens every 2 h, avoiding the sampling of a bird more than once and during 72 h after making medicated feed available for the first time. Serum concentrations of tylosin were determined by HPLC. Gaussian multi-peak regressions were then fitted to serum concentration vs. time profiles. Day by d areas under the serum concentration vs. time profiles (AUC0–24), as well as overall AUC0–72, were statistically higher for the Tpsr group (P < 0.001). Also, maximum serum concentrations obtained and relative bioavailability for the Tpsr formulation were statistically higher (382.8%) as compared to the Tprf group (P < 0.01). Considering the referred improved values of AUC observed in the Tpsr formulation, as well as the fact that tylosin is a time-dependent antibacterial drug, better clinical responses are postulated with this pharmaceutical preparation intended for chickens. Tissue deposition studies for this new formulation of tylosin are required. 相似文献
12.
1. Because tylosin is a time-dependent antibacterial agent, and because feeding and drinking of broilers decreases in late afternoon and ceases in the dark, it was hypothesised that serum concentrations of this drug are greatly reduced during the dark period. 2. The trial was carried out in a commercial poultry house, under standard broiler husbandry conditions, with food and water withdrawn from 22:00 until 07:00 h next morning and exposed to a natural light cycle of 13L:11D. 3. Broilers were given tylosin tartrate, in either feed or water, for 5 d as follows: 100, 200 and 300 ppm in feed, equivalent to 12.6, 25.2 and 37.8 mg/kg/d, respectively; and 200 and 400 mg/l in drinking water, equivalent to 51 to 102 mg/kg/d, respectively. 4. At 07:00 h on d 4, and for the next 40 h, hourly serum samples were obtained and analysed for tylosin by means of a microbiological assay. 5. Day vs night concentrations of tylosin expressed as area under the curve (AUC) in all groups revealed greater values during the day. The highest AUC and AUC(24)/minimal inhibitory concentration (MIC) ratio were obtained in the group medicated with 400 mg/l and the corresponding lowest values were found in the group medicated with 100 ppm in feed. 6. In conclusion, tylosin did not reach therapeutic serum concentrations during the dark period, at all dose rates tested when administered in feed or water. A sustained release form of this drug is needed to solve this inadequacy of tylosin medication in broilers. 相似文献
13.
L.‐W. Ji L.‐L. Dong H. Ji X.‐W. Feng D. Li R.‐L. Ding S.‐X. Jiang 《Journal of veterinary pharmacology and therapeutics》2014,37(3):312-315
The pharmacokinetics and oral bioavailability of tylosin tartrate and tylosin phosphate were carried out in broiler chickens according to a principle of single dose, random, parallel design. The two formulations of tylosin were given orally and intravenously at a dose level of 10 mg/kg b.w to chicken after an overnight fasting (n = 10 chickens/group). Serial blood samples were collected at different time points up to 24 h postdrug administration. A high performance liquid chromatography method was used for the determination of tylosin concentrations in chicken plasma. The tylosin plasma concentration's time plot of each chicken was analyzed by the 3P97 software. The pharmacokinetics of tylosin was best described by a one‐compartmental open model 1st absorption after oral administration. After intravenous administration the pharmacokinetics of tylosin was best described by a two‐compartmental open model, and there were no significant differences between tylosin tartrate and tylosin phosphate. After oral administration, there were significant differences in the Cmax (0.18 ± 0.01, 0.44 ± 0.09) and AUC (0.82 ± 0.05, 1.57 ± 0.25)between tylosin phosphate and tylosin tartrate. The calculated oral bioavailability (F) of tylosin tartrate and tylosin phosphate were 25.78% and 13.73%, respectively. Above all, we can reasonably conclude that, the absorption of tylosin tartrate is better than tylosin phosphate after oral administration. 相似文献
14.
T M Jacks F R Judith S D Feighner R O Likoff 《American journal of veterinary research》1986,47(11):2325-2328
The 21 field isolates of Treponema hyodysenteriae which were tested were sensitive to 3-acetyl-4'-isovaleryl tylosin (AIV); the minimal inhibitory concentration was 0.25 to 16 micrograms/ml. 3-Acetyl-4'-isovaleryl tylosin administered prophylactically to pigs at concentrations of 5 to 100 mg/kg of feed and tylosin at 110 mg/kg of feed for 28 or 31 days prevented swine dysentery induced by tylosin-sensitive T hyodysenteriae strain SQ2; 15 nonmedicated, inoculated control pigs had bloody diarrhea, and 9 pigs died. In 2 additional trials, AIV administered prophylactically for 28 days at 55 or 110 mg/kg of feed prevented swine dysentery induced by tylosin-insensitive T hyodysenteriae strain B204. All of the inoculated principal pigs medicated with AIV at 55 or 110 mg/kg of feed or carbadox at 55 mg/kg of feed and the noninoculated sentinel pigs for each group had solid feces throughout the 56-day trial. In the nonmedicated, inoculated control groups, bloody diarrhea began at 4 to 5 days after inoculation was done, and 9 of 10 principal pigs and 6 of 9 sentinel pigs had dysentery; 2 pigs died. In the groups medicated with AIV at 27.5 or 5.5 mg/kg of feed, all 5 principal pigs and 3 or 4 sentinel pigs in each group had dysentery; 3 or 4 pigs in each group died. In the group medicated with tylosin at 110 mg/kg of feed, 7 of 10 principal pigs and all 9 sentinel pigs had dysentery; 1 pig died.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
15.
Ziv G 《The Veterinary quarterly》1980,2(4):206-210
Summary The minimal inhibitory concentrations (M1C) of tiamulin and tylosin for mycoplasma. Gram-positive, and Gram-negative micro-organisms isolated from chickens were determinated by the agar dilution method. Median M1C values for tiamulin against Mycoplasma gallisepticum (0.05 μg/ml) and Mycoplasma synoviae (0.10 μg/ml) were 2 to 4 times lower than the corresponding values for tylosin. Tiamulin was also slightly more effective in vitro in inhibiting Escherichia coli, Pasteurella multocida, and beta-haemolytic streptococci than was tylosin. Groups of chicken were offered tiamulin medicated drinking water at rates of 125 and 250 mg/litre for 48 hours. Average serum tiamulin concentrations were 0.38 and 0.78 μg/ml, respectively. When tylosin tartrate was added to the drinking water at 500 and 700 mg/litre, average serum drug levels were 0.12 and 0.17 μg/ml, respectively. Tiamulin was 45% bound in chicken serum, as against 30% serum protein binding or tylosin. Correlations were made between free (non protein bound) serum drug levels and the MIC values of the two drugs. Such comparisons suggest that when tiamulin is given in the drinking water at rates of 125 to 250 mg/litre, better antimycoplasmal activity is to be expected in vivo than by giving tylosin tartrate in the drinking water at 500 to 700 mg/litre. Based on these data, no clinical efficacy of these dose rates can be expected in flocks infected by gram-negative microorganisms such as E. coli or P. multocida. The tylosin tartrate rate of 500 to 700 mg/litre, may be clinical ineffective the treatment of Staphylococcus aureus infections. 相似文献
16.
以人工诱发鸡败血霉形体和大肠杆菌混合感染模型,评价氟罗沙星的疗效。按每升水加入２５ｍｇ、５０ｍｇ及１００ｍｇ氟罗沙星及５０ｍｇ环丙沙星的用量给病鸡饮水给药,连续５天,对混合感染鸡的治愈率分别是８６．７％、９０．０％、９０．０％及８３．３％,而感染对照组的死亡率为６３．３％;用药组的相对增重率分别为１０１．３％、１０５．７％、１０７．２％及１０２．４％,均显著高于感染对照组（５８５．５％,Ｐ〈０．０１） 相似文献
17.
18.
G. Ziv 《The Veterinary quarterly》2013,33(4):206-210
Summary The minimal inhibitory concentrations (M1C) of tiamulin and tylosin for mycoplasma. Gram‐positive, and Gram‐negative micro‐organisms isolated from chickens were determinated by the agar dilution method. Median M1C values for tiamulin against Mycoplasma gallisepticum (0.05 μg/ml) and Mycoplasma synoviae (0.10 μg/ml) were 2 to 4 times lower than the corresponding values for tylosin. Tiamulin was also slightly more effective in vitro in inhibiting Escherichia coli, Pasteurella multocida, and beta‐haemolytic streptococci than was tylosin. Groups of chicken were offered tiamulin medicated drinking water at rates of 125 and 250 mg/litre for 48 hours. Average serum tiamulin concentrations were 0.38 and 0.78 μg/ml, respectively. When tylosin tartrate was added to the drinking water at 500 and 700 mg/litre, average serum drug levels were 0.12 and 0.17 μg/ml, respectively. Tiamulin was 45% bound in chicken serum, as against 30% serum protein binding or tylosin. Correlations were made between free (non protein bound) serum drug levels and the MIC values of the two drugs. Such comparisons suggest that when tiamulin is given in the drinking water at rates of 125 to 250 mg/litre, better antimycoplasmal activity is to be expected in vivo than by giving tylosin tartrate in the drinking water at 500 to 700 mg/litre. Based on these data, no clinical efficacy of these dose rates can be expected in flocks infected by gram‐negative microorganisms such as E. coli or P. multocida. The tylosin tartrate rate of 500 to 700 mg/litre, may be clinical ineffective the treatment of Staphylococcus aureus infections. 相似文献
19.
为研究添加不同浓度的酵母硒对吉林芦花鸡生产性能、蛋硒含量、蛋品质、鸡蛋胆固醇含量的影响,试验选用健康的21周龄吉林芦花鸡96只,平均体重1622 g。随机分成4组,每组6个重复,每个重复4只鸡。对照组饲喂基础日粮,其他3组分别添加0.3、0.6、0.9 mg/kg的酵母硒。预试期5 d,正式期21 d。结果表明:各组间料蛋比、采食量、哈氏单位、鸡蛋颜色无显著差异(P>0.05);0.3 mg/kg酵母硒组的平均蛋重极显著低于其他3组(P<0.01),产蛋率、软破壳蛋率均极显著高于其他3组(P<0.01);0.6 mg/kg酵母硒组的蛋黄比率、软破壳蛋率极显著低于其他3组(P<0.01);0.9 mg/kg酵母硒组胆固醇含量极显著低于其他3组(P<0.01);料蛋比(P=0.087)和胆固醇(P=0.061)随着酵母硒添加量的增加有降低的趋势。0.6 mg/kg酵母硒组蛋硒含量极显著高于对照组和0.3 mg/kg酵母硒组(P<0.01),显著高于0.9 mg/kg酵母硒组(P<0.05)。综上,在本试验条件下,酵母硒适宜添加量为0.6 mg/kg。 相似文献